17 results
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... Luminal A-like (ER ... 0111-2 #Early #Breast ... Management #Algorithm #treatment ... #oncology
Treatment of breast cancer: a simplified view
surgical therapy - 5-7 weeks
 - lumpectomy +
 - radiation
Treatment of breast ... 10 years - if ER ... BrighamChiefs #breast ... #cancer #treatment ... timeline #simplified #oncology
Most Common Breast Masses - Comparison between Fibroadenoma, Cysts and Cancer

#Diagnosis #Oncology #Breast #Masses #Comparison #Table
Most Common Breast ... Masses - Comparison ... #Diagnosis #Oncology ... #Breast #Masses ... #Comparison #Table
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
the long-term treatment ... Phentermine/Topiramate ER ... - Naltrexone ER ... /Bupropion ER ... Pharmacology #Table #Comparison
Breast Cancer Subtypes 
Histological Subtypes:
 • Preinvasive: Ductal carcinoma in situ (DCIS). Lobular carcinoma in situ
Breast Cancer Subtypes ... Triple-negative (ER ... s41572-019-0111-2 #Breast ... Cancer #Subtypes #oncology
Tumor Lysis Syndrome
An acute, life-threatening condition that appears within 7 days of starting cytotoxic therapies in
spontaneously (before any treatments ... malignancies Treatments ... hyperkalemia, treat ... acid > 10 mg/dl, treat ... Syndrome #TLS #oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... (A) Suggested treatment ... (B) Suggested treatment ... lead-in of at least ... Management #Hematology #Oncology
Five Year Cancer survival rates in the USA

Despite increasing global cancer deaths, cancer death rates across
, and improved treatment ... who survive at least ... detection and improved treatment ... #Epidemiology #Oncology
Check point inhibitors and Side Effects - Immune-related adverse events (IRAEs)

What are the side effects?
 -
review article- a great ... to months after treatment ... AdverseEffects #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Cytokine Release from blast ... damage • Induce blast ... Renal Failure Treatment ... management #hematology #oncology